Zomedica Corp. (ZOMDF) stock
ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.08−0.00 (-0.55%)
Close on Oct 19, 2026Market cap $77.40MP/E –Yield –
Zomedica operating margin
Operating margin is operating income as a percentage of revenue.
Zomedica's operating margin for the twelve months ending Sep 30, 2026 was -45.4%. For fiscal 2025 it was -263.4%, against -187.1% the year before. The highest annual figure on record is -115.8% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -263.4% | −76.2 |
| FY2024 | Dec 31, 2024 | -187.1% | −15.3 |
| FY2023 | Dec 31, 2023 | -171.8% | −56.0 |
| FY2022 | Dec 31, 2022 | -115.8% | +401.3 |
| FY2021 | Dec 31, 2021 | -517.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -34.6% | +47.0 |
| Q2 FY2026 | Jun 30, 2026 | -42.9% | +72.5 |
| Q1 FY2026 | Mar 31, 2026 | -55.7% | +937.4 |
| Q4 FY2025 | Dec 31, 2025 | -49.3% | +54.0 |
| Q3 FY2025 | Sep 30, 2025 | -81.6% | +24.7 |
| Q2 FY2025 | Jun 30, 2025 | -115.4% | +293.5 |
| Q1 FY2025 | Mar 31, 2025 | -993.0% | −827.2 |
| Q4 FY2024 | Dec 31, 2024 | -103.4% | +211.1 |
| Q3 FY2024 | Sep 30, 2024 | -106.3% | −12.6 |
| Q2 FY2024 | Jun 30, 2024 | -408.9% | −296.9 |
| Q1 FY2024 | Mar 31, 2024 | -165.9% | −28.8 |
| Q4 FY2023 | Dec 31, 2023 | -314.5% | −231.0 |
| Q3 FY2023 | Sep 30, 2023 | -93.7% | +44.3 |
| Q2 FY2023 | Jun 30, 2023 | -112.0% | +26.5 |
| Q1 FY2023 | Mar 31, 2023 | -137.0% | −22.0 |
| Q4 FY2022 | Dec 31, 2022 | -83.4% | +57.8 |
| Q3 FY2022 | Sep 30, 2022 | -138.0% | +27722.8 |
| Q2 FY2022 | Jun 30, 2022 | -138.5% | +33167.8 |
| Q1 FY2022 | Mar 31, 2022 | -115.0% | +27542.1 |
| Q4 FY2021 | Dec 31, 2021 | -141.3% | – |
| Q3 FY2021 | Sep 30, 2021 | -27860.9% | – |
| Q2 FY2021 | Jun 30, 2021 | -33306.3% | – |
| Q1 FY2021 | Mar 31, 2021 | -27657.1% | – |
See a number that looks wrong?